Nicotinamide as Potential Biomarker for Alzheimer’s Disease: A Translational Study Based on Metabolomics

MLA

Martin Aran, et al. Nicotinamide as Potential Biomarker for Alzheimer’s Disease: A Translational Study Based on Metabolomics. July 2021. EBSCOhost, https://doi.org/10.21203/rs.3.rs-518284/v2.

APA

Martin Aran, Silvia Perin, Laura Morelli, Pamela V. Martino Adami, Maria Carolina Dalmasso, Patick Giavalisco, Pablo Galeano, Martin Scherer, Alfredo Ramirez, W. Maier, Steffi Reidel-Heller, A. Claudio Cuello, Eduardo Migual Castano, & Michael Wagner. (2021). Nicotinamide as Potential Biomarker for Alzheimer’s Disease: A Translational Study Based on Metabolomics. https://doi.org/10.21203/rs.3.rs-518284/v2

Chicago

Martin Aran, Silvia Perin, Laura Morelli, Pamela V. Martino Adami, Maria Carolina Dalmasso, Patick Giavalisco, Pablo Galeano, et al. 2021. “Nicotinamide as Potential Biomarker for Alzheimer’s Disease: A Translational Study Based on Metabolomics,” July. doi:10.21203/rs.3.rs-518284/v2.